Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-3249-2026

Philips EPIQ Elite Diagnostic Ultrasound System Model # 795234 Recall

Philips EPIQ Elite Diagnostic Ultrasound System Model # 795234

FDA recall Class II

Ongoing

FDA lists this Class II recall for Philips EPIQ Elite Diagnostic Ultrasound System Model # 795234. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-3249-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Aug 7, 2026
FDA report date
Sep 30, 2026
Quantity in commerce
219 units
Distribution
See key details
FDA cause
Software Design Change

What is being recalled?

Philips EPIQ Elite Diagnostic Ultrasound System Model # 795234

Affected model & UDI checker

Search the exact identifiers published for Z-3249-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
795234Philips EPIQ Elite Diagnostic Ultrasound System Model # 795234Check source noticeNot specified
FDA code information

All Philips EPIQ Elite Ultrasound Systems running software version 14.0, UDI(s): (01)00884838102514 (01)00884838107540 (01)00884838114159 (01)00884838124912 (01)00884838128125

View the original FDA recall notice

Why was this product recalled?

Due to software issue with ultrasound system, doppler sample is displayed shallower than its actual measurement location, potentially causing inaccurate blood flow velocity measurements and misdiagnosis.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Philips Ultrasound, LLC take?

On August 7, 2026, Philips issued a Urgent Medical Device Correction Notification to affected consignees. Philips requested consignees take the following actions: 1. Due to possibility of a weak PW Doppler Signal on EPIQ Elite running 14.0 SW, customers are advised not to use C5-1 Abd Vasc Tissue Specific Preset (TSP). Please use a different TSP (e.g., Abd Gen, Abd Renal) within C5-1. Please note that this issue (i.e., Weak PW Doppler signal) is restricted to the Abd Vasc TSP with C5-1 on EPIQ Elite running SW 14.0 only. 2. Otherwise, you may continue to use your device in accordance with the IFU. 3.Circulate this notice to all users of the device so that they are aware of the product issue and associated hazard / harm. 4. Post this notice near the affected unit(s) for ease of reference 5. Please return the completed response form at the end of this notice, indicating that information on this issue has been read and understood. Philips asks that you return the completed response form no later than 30 days from receipt of this letter.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

Product / regulatory recordCompanyPathwayDecision dateSource
Philips Ultrasound, LLC510(k) clearanceMay 27, 2026FDA
Philips Ultrasound, LLC510(k) clearanceMay 27, 2026FDA

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology